Accolade Ownership | Who Owns Accolade?
Accolade Ownership Summary
Accolade is owned by 83.80% institutional investors, 3.08% insiders, and 13.12% retail investors. Blackrock is the largest institutional shareholder, holding 7.88% of ACCD shares. ARK Genomic Revolution is the top mutual fund, with 5.63% of its assets in Accolade shares.
ACCD Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Accolade | 83.80% | 3.08% | 13.12% |
Sector | Healthcare Stocks | 88.01% | 8.90% | 3.09% |
Industry | Healthcare Information Services Stocks | 54.42% | 10.35% | 35.24% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Blackrock | 6.16M | 7.88% | $22.05M |
Blackrock funding, inc. /de | 6.23M | 7.72% | $21.30M |
Brown advisory | 5.45M | 6.98% | $19.52M |
Ah capital management | 5.40M | 6.91% | $19.33M |
Ark investment management | 4.66M | 5.78% | $15.95M |
Vanguard group | 4.18M | 5.18% | $14.30M |
Deerfield management company, l.p. (series c) | 3.48M | 4.45% | $12.44M |
Jpmorgan chase | 2.96M | 3.79% | $10.59M |
Acadian asset management | 2.98M | 3.70% | $10.19M |
Millennium management | 2.62M | 3.36% | $9.39M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Fairman group | 1.80M | 5.08% | $6.16M |
Ah capital management | 5.40M | 1.65% | $19.33M |
Prosight management, lp | 1.49M | 1.59% | $5.33M |
Rock springs capital management lp | 2.29M | 0.25% | $8.20M |
Deerfield management company, l.p. (series c) | 3.48M | 0.21% | $12.44M |
Johnson financial group | 426.62K | 0.17% | $1.46M |
Ark investment management | 4.66M | 0.13% | $15.95M |
Entrypoint capital | 83.79K | 0.12% | $286.55K |
Requisite capital management | 118.50K | 0.08% | $405.27K |
Clearline capital lp | 830.78K | 0.08% | $2.97M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Millennium management | 2.62M | 0.00% | 1.86M |
Prosight management, lp | 1.49M | 1.59% | 1.49M |
Deerfield management company, l.p. (series c) | 3.48M | 0.21% | 1.09M |
Acadian asset management | 2.98M | 0.03% | 924.57K |
Clearline capital lp | 830.78K | 0.08% | 830.78K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Bellevue group | 842.58K | 0.05% | -3.96M |
Jpmorgan chase | 2.96M | 0.00% | -2.37M |
Rock springs capital management lp | 2.29M | 0.25% | -1.25M |
Gilder gagnon howe | - | - | -920.71K |
Jfg wealth management | - | - | -854.16K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Prosight management, lp | 1.49M | 1.59% | 1.49M | $5.33M |
Clearline capital lp | 830.78K | 0.08% | 830.78K | $2.97M |
Squarepoint ops | 290.74K | 0.00% | 290.74K | $1.04M |
Mirae asset global etfs | 75.94K | 0.00% | 75.94K | $271.85K |
Centiva capital, lp | 56.40K | 0.00% | 56.40K | $201.90K |
Sold Out
Holder | Change |
---|---|
Financial gravity asset management | -3.00 |
Nelson, van denburg & campbell wealth management group | -15.00 |
Quest partners | -20.00 |
Lindbrook capital | -82.00 |
Larson financial group | -96.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 156 | 1.96% | 67,099,488 | 1.94% | 83 | 1.18% | 85 | -1.16% | 45 | 21.62% |
Jun 30, 2024 | 151 | -5.63% | 65,821,616 | -3.55% | 84 | 1.05% | 84 | 5.00% | 37 | -19.57% |
Mar 31, 2024 | 160 | 5.96% | 68,242,926 | 1.83% | 89 | 1.16% | 80 | 15.94% | 46 | -6.12% |
Dec 31, 2023 | 151 | -7.93% | 67,013,210 | 15.62% | 88 | 1.49% | 69 | -13.75% | 49 | 40.00% |
Sep 30, 2023 | 164 | -4.09% | 57,959,805 | 3.41% | 76 | 1.31% | 80 | 6.67% | 35 | -31.37% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
ARK Genomic Revolution | 4.60M | 5.63% | -744.99K |
ARK Genomic Revolution ETF | 3.51M | 4.29% | -102.50K |
Vanguard Total Stock Mkt Idx Inv | 2.21M | 2.71% | - |
iShares Russell 2000 ETF | 1.94M | 2.38% | -14.75K |
Brown Advisory Small-Cap Growth Inv | 1.49M | 1.85% | -69.33K |
Vanguard Institutional Extnd Mkt Idx Tr | 1.14M | 1.39% | - |
Nikko AM ARK Pstv Chg Innovt P JPY Acc | 1.14M | 1.39% | -5.48K |
Kennedy Micro Cap | 870.62K | 1.07% | 294.89K |
Nikko Gbl All Biological Genome Eq MF | 836.63K | 1.04% | -108.67K |
Fidelity Small Cap Index | 699.63K | 0.86% | -41.87K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Feb 04, 2025 | Barnes Stephen H. | Chief Financial Officer | Sell | $3.10K |
Feb 04, 2025 | Cavanaugh Robert N | President | Sell | $3.86K |
Feb 04, 2025 | SINGH RAJEEV | Chief Executive Officer | Sell | $8.10K |
Feb 04, 2025 | Eskew Richard | EVP General Counsel | Sell | $2.70K |
Jan 17, 2025 | Cavanaugh Robert N | President | Sell | $1.28K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | 15 |
2024 Q4 | - | 33 |
2024 Q3 | - | 33 |
2024 Q2 | - | 27 |
2024 Q1 | - | 29 |
ACCD Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools